Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...
After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.
Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...
A new study published in Nature Communications shows that oral fecal microbiota transplantation (FMT) is a feasible and safe ...
New Treatments for HR-Positive Breast Cancer and Mantle Cell Lymphoma Offer Promising Outcomes and Expanded Options for ...
The combination of treosulfan and fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation ...
The FDA approved treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell ...
who are ineligible for autologous hematopoietic stem cell transplantation. The approval followed the FDA granting the application with Priority Review status and with support from the Phase III ECHO ...
A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus ...